Several radioimmunoassays (RIAs) for the measurement of methotrexate (MTX), all of which use tritiated drug as tracer, have been described (Bohuon et al., 1974;  Levine and Powers, 1974;  Raso and Schreiber, 1975; Hendel et al., 1976; Loeffler et al., 1976;  Aherne et al., 1977) . RIA techniques for the measurement of MTX are extremely sensitive and are being used increasingly in the clinical situation. However, there are obvious practical disadvantages in the use of tritiated labels: scintillation fluid is expensive; time-eonsuming sample preparation is necessary before scintillation counting can be carried out; counting time is usually longer than for gamma emitters; disposal of large quantities of radioactive scintillation fluid can be a problem; and used scintillation vials are expensive to replace.
These disadvantages can be overcome by the use of a gamma-emitting radiolabeI. Several commercial radioassay kits which use 125I-Iabelled MTX are available (New England Enzyme Centre, Boston, Mass; Diagnostic Biochemistry Inc, San Diego, Calif) but there have been no reports on its actual preparation. The use of 75Se-labelled MTX in our radioimmunoassay is reported.
Material and methods

ANTISERUM
The preparation of specific MTX antiserum has been described (Aherne et al., 1977) and the same antiserum bleed HPjSj3 llA has been used for this work. The antiserum was used in the RIA at a final dilution of 1 :24 000. The procedure for using 75Se-MTXin the RIA ( Table  1 ) differs from that previously described in that, after the addition of dextran-coated charcoal and centri- Incubate 50 min at room temperature followed by 10 min at 4"C 100 100 100
Leave for 10 min Centrifuge. aspirate supernatant, and count charcoal pellet 331 300 100 100 100 100 The figure shows the mean curve of 10 consecutive MTX standard curves obtained using both 75Se_ MTX and 3H-MTX. The data used to construct these curves are given in Table 2 . Since less labelled MTX was added to the 76Se-curves it was possible to incorporate in these curves a O:5ngjml standard point. The sensitivity of each assay was calculated to be 550 pgjml (1'21 x 10-9 M) when 3H-MTX was used and 340 pgjml (0'75 x 10-9 M) when 75Se-MTX was used (Albano and Ekins, 1970) . The addition of 50 JlJ of normal serum and urine did not affect the shape of the standard curve, and serial dilutions of both serum or urine samples known to contain MTX were superimposable on the standard curve.
ASSA Y OF CLINICAL SAMPLES
A pool of sera from patients receivingMTX as part of their treatment was assayed several times in the course of two weeks using both RIA methods. A mean concentration of 899 ngjml (1'98 x 10-6 M) n = 8, coefficient of variance 12'4%, was obtained using 76Se-labelled MTX compared with a mean concentration of 948 ngjml (2'09 x 10-6 M) n = IS, coefficient of variance 9'6%, when 3H-MTX was used.
At a MTX concentration of 98 ngjml (0'22 x 10-6 M) the coefficient of variance was 5'2 % (n = 5) using 75Se-MTX compared with a coefficient of variance of 5·8 % (n = 10) for a similar sample of mean concentration 105 ngjml using 3H-MTX.
The MTX concentration in 150 serum and urine samples obtained from patients receiving MTX treatment was measured by RIA using both labels. Table 2 ).
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Results
STORAGE OF LABEL
The 75Se-MTX was stable for at least six months when stored frozen. During that period there was no loss of immunoreactivity although the actual count rate decreased according to the half-life of 75Se. The difference between the counts in the total tube and the counts in the charcoal pellet of the NSB tubes represented nonspecific binding and was 1-5% of the total radioactivity added. A marked increase (5-10% of total reactivity) in this value and decreased immunoreactivity indicated a deterioration of the label and occurred if the label was stored at 4°C for more than one to two weeks. Working solutions of label could be stored at 4°C for up to 48 hours without loss of antibody binding.
fugation, the supernatant containing the antibodybound fraction was aspirated and the charcoal pellet, or free fraction, was counted in a Wallac 80000 gamma counter. Results were calculated as a percentage of the counts in the nonspecific bound (NSB) tubes. The specificity of the antiserum was checked using 75Se-MTX and compared with the specificity of the same antiserum when 3H-MTX was used (Table 3) . The cross-reaction of various analogues and metabolites of MTX was expressed as the ratio of the amounts required to produce equivalent (50% of zero) displacement of labelled MTX. The crossreaction of 7-hydroxy-MTX in the case of 75Se-MTX was thought to be due entirely to 2 %contamination by unchanged MTX of this batch of7-hydroxy-MTX which was different from that used with 3H-MTX. Ten micrograms of several chemotherapeutic agents likely to be prescribed with MTX did not affect the binding of 3H-MTX to antibody (Aherne et al., 1977) and it is unlikely that they would crossreact when 75Se-MTX is used. between the methods over an extremely large range of concentrations was obtained. The overall order of specificity of the antiserum was the same with both labels although the degree of cross-reaction ofvarious analogues and metabolites was slightly different. This may reflect different avidities of the antiserum for the two labels.
There is increasing evidence for the need routinely to monitor MTX concentrations during and after treatment with the drug (Freeman-Narrod et al., 1975; Frei et al., 1975; Shapiro et al., 1975; Stoller et al., 1977; Aherne et al., 1978) . RIA, especially if a gamma-emitting isotope is available, is an ideal technique for clinical monitoring of patients receiving chemotherapy. Besides the practical advantages of gamma counting, results can be made available in a much shorter time since time involved with sample preparation after centrifugation and counting is reduced. By reducing the incubation period for antigen-antibody reaction to 15-30 minutes results can be obtained within one to three hours of the sample being taken. The availability of a method such as we have described increases the feasibility of monitoring MTX in a much larger number of centres than is possible at present.
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75Se-labelled MTX ligand has several practical advantages over 3H-MTX as a label in the RIA of MTX. The gamma-labelled preparation of MTX is extremely stable if stored at -20 cC and can be used for longer than its radioactive half-life (121 days) without any decrease in immunoreactivity. Storage of 3H-MTX is not without its problems since there is a marked decrease in immunoreactivity with time if this label is not stored in liquid nitrogen or if diluted stocks are stored at 4"C, Because of the greater efficiency of gamma counting over scintillation counting, the amount of 75Se-MTX added to the assay tube (0'5 pmol) was half that added when 3H-MTX was used. Consequently, a O' 5 ng/ml (1'1 x 10-9 M) standard point could be incorporated into the standard curve. This increased sensitivity was extremely useful for detecting residual levels of MTX two to seven days after administration of the drug. For the majority of samples, however, increased sensitivity is not required since multiple dilutions of samples are usually necessary. The interassay precision of the modified assay was of the same order as for 3H-MTX, and a significant correlation
